Literature DB >> 10908660

A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-alpha signaling.

T C Yeh1, E Dondi, G Uze, S Pellegrini.   

Abstract

Tyrosine kinases of the Janus kinase family initiate cellular responses through their association with receptors for alpha-helical cytokines. In addition to a tyrosine kinase domain, these enzymes possess a kinase-like (KL) domain, whose function remains elusive. To investigate the role of the KL domain of Tyk2 in interferon-alpha/beta signaling, we transfected a library of Tyk2 cDNAs containing random point mutations in KL into Tyk2-negative cells and selected for loss-of-function Tyk2 mutants. Four such mutants, V584D, G596V, H669P, and R856G, were identified through this screen. Like the wild-type Tyk2, the mutant proteins were able to sustain the level of IFNAR1 receptor protein. However, all four mutants were incapable of restoring high-affinity interferon-alpha binding in Tyk2-negative cells and were also catalytically impaired, even when transiently overexpressed. Interferon-alpha induced phosphorylation, and gene expression could be detected in V584D- or G596V-expressing cells, but not in H669P- or R856G-expressing cells. Furthermore, H669P and R856G proteins were constitutively highly phosphorylated. All together, our findings demonstrate that an intact KL domain is essential for the intrinsic catalytic activity of Tyk2 and for the establishment of a high-affinity interferon-alpha receptor complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908660      PMCID: PMC16809          DOI: 10.1073/pnas.160130297

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

Review 1.  The type I interferon receptor: structure, function, and evolution of a family business.

Authors:  K E Mogensen; M Lewerenz; J Reboul; G Lutfalla; G Uzé
Journal:  J Interferon Cytokine Res       Date:  1999-10       Impact factor: 2.607

2.  A protein tyrosine kinase in the interferon alpha/beta signaling pathway.

Authors:  L Velazquez; M Fellous; G R Stark; S Pellegrini
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

3.  Randomization of genes by PCR mutagenesis.

Authors:  R C Cadwell; G F Joyce
Journal:  PCR Methods Appl       Date:  1992-08

Review 4.  The type-I interferon receptor. The long and short of it.

Authors:  P Domanski; O R Colamonici
Journal:  Cytokine Growth Factor Rev       Date:  1996-08       Impact factor: 7.638

Review 5.  The glycine-rich sequence of protein kinases: a multifunctional element.

Authors:  D Bossemeyer
Journal:  Trends Biochem Sci       Date:  1994-05       Impact factor: 13.807

6.  Use of a selectable marker regulated by alpha interferon to obtain mutations in the signaling pathway.

Authors:  S Pellegrini; J John; M Shearer; I M Kerr; G R Stark
Journal:  Mol Cell Biol       Date:  1989-11       Impact factor: 4.272

Review 7.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

8.  Crystal structure of the tyrosine kinase domain of the human insulin receptor.

Authors:  S R Hubbard; L Wei; L Ellis; W A Hendrickson
Journal:  Nature       Date:  1994 Dec 22-29       Impact factor: 49.962

9.  Activation of the protein tyrosine kinase tyk2 by interferon alpha/beta.

Authors:  G Barbieri; L Velazquez; M Scrobogna; M Fellous; S Pellegrini
Journal:  Eur J Biochem       Date:  1994-07-15

10.  Predicted tyk2 protein contains two tandem protein kinase domains.

Authors:  A Bernards
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

View more
  27 in total

1.  Regulation of Jak2 through the ubiquitin-proteasome pathway involves phosphorylation of Jak2 on Y1007 and interaction with SOCS-1.

Authors:  Daniela Ungureanu; Pipsa Saharinen; Ilkka Junttila; Douglas J Hilton; Olli Silvennoinen
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

2.  Autoinhibition of Jak2 tyrosine kinase is dependent on specific regions in its pseudokinase domain.

Authors:  Pipsa Saharinen; Mauno Vihinen; Olli Silvennoinen
Journal:  Mol Biol Cell       Date:  2003-04       Impact factor: 4.138

Review 3.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

4.  Structural and Functional Characterization of the JH2 Pseudokinase Domain of JAK Family Tyrosine Kinase 2 (TYK2).

Authors:  Xiaoshan Min; Daniela Ungureanu; Sarah Maxwell; Henrik Hammarén; Steve Thibault; Ellin-Kristina Hillert; Merrill Ayres; Brad Greenfield; John Eksterowicz; Chris Gabel; Nigel Walker; Olli Silvennoinen; Zhulun Wang
Journal:  J Biol Chem       Date:  2015-09-10       Impact factor: 5.157

5.  Associations between PXK and TYK2 polymorphisms and systemic lupus erythematosus: a meta-analysis.

Authors:  Young Ho Lee; Sung Jae Choi; Jong Dae Ji; Gwan Gyu Song
Journal:  Inflamm Res       Date:  2012-05-17       Impact factor: 4.575

6.  Combining multiple structure and sequence alignments to improve sequence detection and alignment: application to the SH2 domains of Janus kinases.

Authors:  B Al-Lazikani; F B Sheinerman; B Honig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

7.  ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation.

Authors:  Henrik M Hammarén; Daniela Ungureanu; Jean Grisouard; Radek C Skoda; Stevan R Hubbard; Olli Silvennoinen
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-30       Impact factor: 11.205

Review 8.  Molecular insights into regulation of JAK2 in myeloproliferative neoplasms.

Authors:  Olli Silvennoinen; Stevan R Hubbard
Journal:  Blood       Date:  2015-03-30       Impact factor: 22.113

9.  The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the type 1 interferon receptor.

Authors:  Rinki Minakshi; Kartika Padhan; Manjusha Rani; Nabab Khan; Faizan Ahmad; Shahid Jameel
Journal:  PLoS One       Date:  2009-12-17       Impact factor: 3.240

10.  A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction.

Authors:  Sabine A Bisson; Anne-Laure Page; Don Ganem
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.